<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMJ Case Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">BMJ Case Rep</journal-id>
<journal-id journal-id-type="hwp">casereports</journal-id>
<journal-id journal-id-type="publisher-id">bmjcasereports</journal-id>
<journal-title-group>
<journal-title>BMJ Case Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">1757-790X</issn>
<publisher>
<publisher-name>BMJ Publishing Group</publisher-name>
<publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28963116</article-id>
<article-id pub-id-type="pmc">5652380</article-id>
<article-id pub-id-type="publisher-id">bcr-2017-220778</article-id>
<article-id pub-id-type="doi">10.1136/bcr-2017-220778</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Rare Disease</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>1523</subject>
<subject>159</subject>
</subj-group>
<subj-group subj-group-type="search-fields">
<subject>Male</subject>
<subject>31-50 years</subject>
<subject>White</subject>
<subject>Europe (West)</subject>
</subj-group>
<series-title>Case Report</series-title>
</article-categories>
<title-group>
<article-title>Phelan-McDermid syndrome due to <italic>SHANK3</italic> mutation in an intellectually disabled adult male: successful treatment with lithium</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="author-23330772">
<name>
<surname>Egger</surname>
<given-names>Jos I M</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Verhoeven</surname>
<given-names>Willem M A</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Groenendijk-Reijenga</surname>
<given-names>Renske</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kant</surname>
<given-names>Sarina G</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution content-type="department">Centre of Excellence for Neuropsychiatry</institution>, <institution>Vincent van Gogh Institute of Psychiatry</institution>, <addr-line content-type="city">Venray</addr-line>, <country>Netherlands</country></aff>
<aff id="aff2"><label>2</label><institution content-type="department">Donders Institute for Brain, Cognition and Behaviour, Centre for Cognition</institution>, <institution>Radboud University</institution>, <addr-line content-type="city">Nijmegen</addr-line>, <country>Netherlands</country></aff>
<aff id="aff3"><label>3</label><institution content-type="department">Department of Psychiatry</institution>, <institution>Erasmus University Medical Centre</institution>, <addr-line content-type="city">Rotterdam</addr-line>, <country>Netherlands</country></aff>
<aff id="aff4"><label>4</label><institution content-type="department">Centre for People with Intellectual Disabilities</institution>, <institution>Ipse de Bruggen</institution>, <addr-line content-type="city">Zwammerdam</addr-line>, <country>Netherlands</country></aff>
<aff id="aff5"><label>5</label><institution content-type="department">Department of Clinical Genetics</institution>, <institution>Leiden University Medical Centre</institution>, <addr-line content-type="city">Leiden</addr-line>, <country>Netherlands</country></aff>
<author-notes>
<corresp><label>Correspondence to</label> Professor Jos I M Egger, <email>j.egger@psych.ru.nl</email></corresp>
<fn fn-type="COI-statement">
<p><bold>Competing interests:</bold> None declared.</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>9</month>
<year>2017</year>
</pub-date>
<volume>2017</volume>
<elocation-id>bcr2017220778</elocation-id>
<history>
<date date-type="accepted">
<day>15</day>
<month>9</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="bcr-2017-220778.pdf" xlink:title="pdf"></self-uri>
<abstract>
<p>For 30 years, Phelan and co-workers described a syndrome characterised by neonatal hypotonia, global developmental delay, strongly impaired speech, sleep disturbances and hyperreactivity to sensory stimuli. This Phelan-McDermid syndrome (PMS), also presenting with symptoms from the autism spectrum and a higher risk of developing seizure disorders, may be caused by a deletion of chromosome 22q13 or by a mutation in the <italic>SHANK3</italic> gene. Its core psychopathological phenotype comprises symptoms from the bipolar spectrum for which generally treatment with a mood-stabilising anticonvulsant in combination with an atypical antipsychotic seems to be most effective. In addition to two elsewhere published adolescent patients, we here describe in detail the history of an adult male patient with PMS caused by a <italic>SHANK3</italic> mutation in whom successive treatment regimens with antipsychotics and mood-stabilising anticonvulsants were all ineffective. Ultimately, addition of lithium to existing olanzapine therapy led to enduring stabilisation of mood and behaviour.</p>
</abstract>
<kwd-group>
<kwd>genetics</kwd>
<kwd>psychiatry</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>